Cargando…
Bremelanotide for Treatment of Female Hypoactive Sexual Desire
Hypoactive sexual desire disorder (HSDD) is a persistent deficiency or absence of sexual fantasies and desire resulting in significant distress or interpersonal difficulty. Women with this disorder may display a lack of motivation for sexual activity, reduced responsiveness to erotic cues, a loss of...
Autores principales: | Edinoff, Amber N., Sanders, Nicole M., Lewis, Kyle B., Apgar, Tucker L., Cornett, Elyse M., Kaye, Adam M., Kaye, Alan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788464/ https://www.ncbi.nlm.nih.gov/pubmed/35076581 http://dx.doi.org/10.3390/neurolint14010006 |
Ejemplares similares
-
Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2019) -
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
por: Kingsberg, Sheryl A., et al.
Publicado: (2019) -
Flibanserin: A controversial drug for female hypoactive sexual desire disorder
por: Baid, Rashmi, et al.
Publicado: (2018) -
Flibanserin for Treating Hypoactive Sexual Desire Disorder
por: Sang, Jae Hong, et al.
Publicado: (2016) -
Evaluation and Management of Hypoactive Sexual Desire Disorder
por: Clayton, Anita H., et al.
Publicado: (2018)